Active Pharmaceutical Ingredients

The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products

Takeda Openes First API Manufacturing Plant outside Japan

Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland. The company CEO, government ministers and industry officials together with staff and guests ...
api

FDA Warned Three Repackers of API for Violations of CGMP Requirements

The U.S. Food and Drug Administration has issued warning letters to three repackers of active pharmaceutical ingredients (API), B&B Pharmaceuticals, Inc., Asclemed USA, Inc., doing business as Eno...

Concept Life Sciences Opens New Facility

Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, has unveiled a new, state-of-the-art clinical and niche commercial facility to support p...

Chugai Pharmaceutical to Construct a New Facility for API

Chugai Pharmaceutical Co., Ltd. (hereafter, “Chugai”) announced today the decision to construct a new manufacturing building for active pharmaceutical ingredients (APIs) for clinical studies in Fujied...

CPI Partenrs with GSK and AZ to Create New Site

GSK, AstraZeneca, and GEA join resources to create a site in the UK for developing small-scale oral solid dosage APIs. CPI is collaborating with partners GSK and AstraZeneca to establish a bespoke,...

WuXi STA Passed First GMP Inspection by MPA

STA Pharmaceutical Co., Ltd., – a subsidiary of WuXi AppTec – announces that its new drug product manufacturing facility in Shanghai Pilot Free Trade Zone has passed its first GMP inspection by the Eu...

Video

Expert opinion